FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

372520005: Azelastine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1197813016 Azelastine (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1211054014 Azelastine en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Azelastine Is a Phthalazinone derivative true Inferred relationship Existential restriction modifier
Azelastine Is a Non-sedating antihistamine false Inferred relationship Existential restriction modifier
Azelastine Has disposition Histamine H1 receptor antagonist true Inferred relationship Existential restriction modifier
Azelastine Is a Substance with histamine H1 receptor antagonist mechanism of action true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Azelastine hydrochloride Is a False Azelastine Inferred relationship Existential restriction modifier
Product containing azelastine Has active ingredient True Azelastine Inferred relationship Existential restriction modifier 1
Azelastine adverse reaction Causative agent True Azelastine Inferred relationship Existential restriction modifier 1
Allergy to azelastine Causative agent False Azelastine Inferred relationship Existential restriction modifier
Product containing azelastine in ophthalmic dosage form Has active ingredient False Azelastine Inferred relationship Existential restriction modifier
Product containing azelastine in nasal dose form (medicinal product form) Has active ingredient True Azelastine Inferred relationship Existential restriction modifier 1
Allergy to azelastine Causative agent True Azelastine Inferred relationship Existential restriction modifier 1
Azelastine hydrochloride Is modification of True Azelastine Inferred relationship Existential restriction modifier
Product containing azelastine in ocular dose form (medicinal product form) Has active ingredient True Azelastine Inferred relationship Existential restriction modifier 1
Azelastine Has active ingredient True Azelastine Inferred relationship Existential restriction modifier 1
Product containing only azelastine in nasal dose form (medicinal product form) Has active ingredient True Azelastine Inferred relationship Existential restriction modifier 1
Product containing only azelastine in ocular dose form (medicinal product form) Has active ingredient True Azelastine Inferred relationship Existential restriction modifier 1
Product containing azelastine and fluticasone (medicinal product) Has active ingredient True Azelastine Inferred relationship Existential restriction modifier 1
Fluticasone + Azelastine Has active ingredient True Azelastine Inferred relationship Existential restriction modifier 1
Product containing only azelastine and fluticasone in nasal dose form (medicinal product form) Has active ingredient True Azelastine Inferred relationship Existential restriction modifier 1
Product containing azelastine and fluticasone in nasal dose form (medicinal product form) Has active ingredient True Azelastine Inferred relationship Existential restriction modifier 1
Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) Has active ingredient False Azelastine Inferred relationship Existential restriction modifier
Azelastine 0.05% eye drops Has active ingredient False Azelastine Inferred relationship Existential restriction modifier
Optilast 0.05% eye drops (Viatris UK Healthcare Ltd) Has active ingredient True Azelastine Inferred relationship Existential restriction modifier
Aller-Eze 0.05% eye drops (Novartis Consumer Health UK Ltd) Has active ingredient True Azelastine Inferred relationship Existential restriction modifier
Optilast 0.05% eye drops (Mawdsley-Brooks & Company Ltd) Has active ingredient True Azelastine Inferred relationship Existential restriction modifier
Fluticasone + Azelastine Has active ingredient False Azelastine Inferred relationship Existential restriction modifier
Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray Has active ingredient False Azelastine Inferred relationship Existential restriction modifier
Dymista 137micrograms/dose / 50micrograms/dose nasal spray (Viatris UK Healthcare Ltd) Has active ingredient True Azelastine Inferred relationship Existential restriction modifier
Optilast 0.05% eye drops (Waymade Healthcare Plc) Has active ingredient True Azelastine Inferred relationship Existential restriction modifier
Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) Has active ingredient False Azelastine Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start